The scheme will facilitate the creation of 50,000 urban infrastructure projects and generate wage employment for over five ...

For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...

The Odisha state cabinet approved a new flagship scheme, Development of Biotechnology, on Friday (6 June), The New Indian ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...